about
Immunity and early atherosclerosis in the course of systemic lupus erythematosus, mixed connective tissue disease and antiphospholipid syndromeTolerization against atherosclerosis using heat shock protein 60Therapy insight: systemic lupus erythematosus as a risk factor for cardiovascular diseaseStatin therapy and autoimmune disease: from protein prenylation to immunomodulationChlamydia pneumoniae exacerbates aortic inflammatory foci caused by murine cytomegalovirus infection in normocholesterolemic miceOxidative risk for atherothrombotic cardiovascular disease.TNFalpha regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation.Inflammatory and autoimmune reactions in atherosclerosis and vaccine design informatics.Atherosclerosis, inflammation, and infection.Modified LDL - trigger of atherosclerosis and inflammation in the arterial intima.Immunomodulation of atherosclerosis: myth and reality.Accelerated atheroma in lupus--background.Autoimmunity in atherosclerosis: lessons from experimental models.The unfolding story of the chaperonins.Growth in vascular cells and cytokine production by Chlamydia pneumoniae.γδT cells are prevalent in the proximal aorta and drive nascent atherosclerotic lesion progression and neutrophilia in hypercholesterolemic mice.The role of inflammatory and immunological mediators in periodontitis and cardiovascular disease.The association between periodontal diseases and cardiovascular diseases: a state-of-the-science review.Novel network biomarkers profile based coronary artery disease risk stratification in Asian Indians.Role of leptin as an immunomodulator of blood mononuclear cells: mechanisms of action.High titres of serum antinuclear antibodies, mostly directed against nucleolar antigens, are associated with the presence of coronary atherosclerosis.Increased titres of anti-human heat shock protein 60 predict an adverse one year prognosis in patients with acute cardiac chest painVaccination to modulate atherosclerosisAutoantibodies against heat shock protein 60 mediate endothelial cytotoxicity.Association of anti-oxidized LDL and candidate genes with severity of coronary stenosis in the Women's Ischemia Syndrome Evaluation studyInhibition of atherosclerosis in CD4 T-cell-ablated and nude (nu/nu) C57BL/6 hyperlipidemic miceCD1 expression in human atherosclerosis. A potential mechanism for T cell activation by foam cells.'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals.Innate immune signaling and Porphyromonas gingivalis-accelerated atherosclerosis.Suppressive effects of anti-inflammatory agents on human endothelial cell activation and induction of heat shock proteins.Heat shock proteins: pathogenic role in atherosclerosis and potential therapeutic implications.The prevention and management of stroke in sickle cell anaemia.Concentration of circulating autoantibodies against HSP 60 is lowered through diving when compared to non-diving ratsIn vivo imaging of the effect of LPS on arterial endothelial cells: molecular imaging of heat shock protein 60 expression.Potential mechanism for recruitment and migration of CD133 positive cells to areas of vascular inflammation.Risk of Atherosclerosis and Helicobacter pylori Infection according to CD14 Promotor Polymorphism in Healthy Korean Population.IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.Expression levels of heat shock protein 60 in human endothelial cells in vitro are unaffected by exposure to 50 Hz magnetic fields.Oral hygiene status of individuals with cardiovascular diseases and associated risk factors.
P2860
Q28071723-143ECDAC-A0AB-4AAA-9F39-0D97EE8BF040Q28081051-313556CB-F602-4519-A616-154F00A3123FQ28188901-52AAD84D-3046-42EA-982B-35147962E0C5Q28236647-184DF648-9E09-4736-A607-4A71AB081DA4Q28362988-02DEF7D2-68AE-48CF-A4EB-317D1E4DB877Q33554184-5D70E883-90B0-4E6C-A10F-A6A33EB3F231Q33688721-F7FFD6A1-48A1-4B3D-B3C4-EEFA805B02B3Q33805176-D7C76786-4C2F-47E7-A81C-F070A04DB4D2Q33843534-85307B39-16F7-4FCD-B715-533AA7C5AD74Q33890396-CD2EA4A9-9EBF-4E7A-B24C-CB3B26C34F73Q33890414-E832878C-2194-4B3F-9035-9D29B96D9CB4Q33915419-B47C5C3F-99B9-4A83-823A-570C7E0124C8Q33915478-89362722-3C2C-481C-A732-6FC6D95AD7F9Q33923440-5DF553FD-4E68-4F2D-BCAA-F412C5A777D8Q33935046-936B6510-061C-45F2-BB23-031D07F5F92AQ34337885-19B99CC4-E451-4C73-BDA6-C9378882302CQ34557697-79A62B61-DDED-4B9E-A722-2D6CD7434A6FQ34557726-26F35933-7BE9-4DB0-B070-E759261438B3Q35040467-E1B73317-91DC-4A27-B36E-2C45E4CABEC4Q35161166-15D76738-0050-485F-A973-3E4D369927B0Q35551274-1E4BD859-8217-45CE-9B61-E1F785A5C444Q35584657-03375047-2BA6-46E9-8649-400020A73EEEQ35600876-E2B05B42-D33D-48E9-BA6D-B2E6515B7E2FQ35767608-CD70E0F9-468C-4A5C-8381-7776CEC26325Q35771169-6893AC91-63C1-43BF-BE04-009626C23876Q35782654-5730E35F-8569-4381-A021-9E8302618E1CQ35787847-78C60ABC-D326-4287-B924-8ED8E29BE590Q36290168-B1F1AF94-F017-4EF6-ADBA-512CE6D689C3Q36365548-5A06F38B-0133-4BF8-913F-8FC8BD2BC5C5Q36376749-CE09718D-94FD-4FCE-8B9D-A57E7B461061Q36438422-99814355-E85A-443B-A0D1-004935485548Q36488793-7A19AD56-C4C2-4A9B-962E-7F3A7EA64EB0Q36627220-C81D7E6D-C736-46F0-913C-16A47F2F76C9Q37106077-41CF9E38-6473-41C1-8277-6C602C4B3245Q37171018-17331859-1E02-4EF3-A7AC-34B8D0E10E56Q37182873-E177596C-27F4-49F4-BB84-E51B0F6CEEE8Q37283498-F375BE75-4A44-48ED-9F07-12C38FCB51D3Q37368296-D9C8AAF6-31C6-4F4D-94DD-16895846784BQ37490732-48DBCA5E-353C-49A4-B40A-1F56FCFF1A85Q37694109-7A4A9F6A-719E-4C4C-8FCB-048D4E83FEC1
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Is atherosclerosis an immunologically mediated disease?
@en
type
label
Is atherosclerosis an immunologically mediated disease?
@en
prefLabel
Is atherosclerosis an immunologically mediated disease?
@en
P2093
P1433
P1476
Is atherosclerosis an immunologically mediated disease?
@en
P2093
P356
10.1016/0167-5699(95)80067-0
P577
1995-01-01T00:00:00Z